Your browser doesn't support javascript.
loading
Serum ferritin levels at diagnosis predict prognosis in patients with low blast count myelodysplastic syndromes.
Kawabata, Hiroshi; Usuki, Kensuke; Shindo-Ueda, Maki; Kanda, Junya; Tohyama, Kaoru; Matsuda, Akira; Araseki, Kayano; Hata, Tomoko; Suzuki, Takahiro; Kayano, Hidekazu; Shimbo, Kei; Chiba, Shigeru; Ishikawa, Takayuki; Arima, Nobuyoshi; Nohgawa, Masaharu; Miyazaki, Yasushi; Kurokawa, Mineo; Arai, Shunya; Mitani, Kinuko; Takaori-Kondo, Akifumi.
  • Kawabata H; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan. hkawabat@kanazawa-med.ac.jp.
  • Usuki K; Department of Hematology and Immunology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa-ken, 920-0293, Japan. hkawabat@kanazawa-med.ac.jp.
  • Shindo-Ueda M; Department of Hematology, NTT Medical Center Tokyo, Tokyo, Japan.
  • Kanda J; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Tohyama K; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Matsuda A; Department of Laboratory Medicine, Kawasaki Medical School, Okayama, Japan.
  • Araseki K; Department of Hemato-Oncology, International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan.
  • Hata T; Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Saitama Medical University, Moroyama, Saitama, Japan.
  • Suzuki T; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Kayano H; Department of Hematology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.
  • Shimbo K; School of Medical Technology, Faculty of Health and Medical Care, Saitama Medical University, Hidaka, Saitama, Japan.
  • Chiba S; Clinical Laboratory Center, Dokkyo Medical University Hospital, Mibu, Tochigi, Japan.
  • Ishikawa T; Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Arima N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
  • Nohgawa M; Department of Hematology, Medical Research Institute Kitano Hospital, Osaka, Japan.
  • Miyazaki Y; Department of Hematology, Japanese Red Cross Wakayama Medical Center, Wakayama, Japan.
  • Kurokawa M; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan.
  • Arai S; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Mitani K; Department of Hematology, Tokyo Metropolitan Police Hospital, Tokyo, Japan.
  • Takaori-Kondo A; Department of Hematology and Oncology, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Int J Hematol ; 110(5): 533-542, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31359362
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Ferritinas Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Síndromes Mielodisplásicos / Ferritinas Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male País como asunto: Asia Idioma: En Año: 2019 Tipo del documento: Article